{
    "clinical_study": {
        "@rank": "127825", 
        "acronym": "PED-CXL", 
        "arm_group": {
            "arm_group_label": "Conventional CXL", 
            "arm_group_type": "Experimental", 
            "description": "Crosslinking was done according to the standard protocol using hypo-osmolar riboflavin to saturate the cornea following epithelial debridement and ultra - violet light of 370nm with energy density of 3 milliwatts/sq.cm with riboflavin and distilled water alternated every 2 minutes was used for the procedure."
        }, 
        "brief_summary": {
            "textblock": "Keratoconus is a chronic progressive non - inflammatory disorder characterised by\n      progressive steepening and thinning of cornea and high myopic astigmatism, accounting for\n      poor visual acuity in such individuals. Keratoconus seems to be more advanced on\n      presentation, in young patients.\n\n      The investigators intend to evaluate the effectiveness of conventional collagen cross\n      linking in young patients diagnosed with keratoconus."
        }, 
        "brief_title": "Conventional Collagen Crosslinking in Young Keratoconus", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Keratoconus", 
        "condition_browse": {
            "mesh_term": "Keratoconus"
        }, 
        "detailed_description": {
            "textblock": "Keratoconus is progressive ectatic corneal disorder characterised by progressive corneal\n      thinning, steep corneal curvatures and usually associated with high irregular myopic\n      astigmatism.\n\n      The major problems concerning keratoconus in young patients are;\n\n        1. Rapid rates of progression in young keratoconic corneas as compared to adults.\n\n        2. Poor biomechanical properties of young corneas.\n\n        3. Poor quality of vision, which predisposes to a very poor quality of life.\n\n        4. High rates of complications and failure post keratoplasty in young patients.\n\n      The investigators intend to evaluate the effectiveness of conventional collagen crosslinking\n      in young patients with keratoconus with regards to keratometric indices and visual acuity."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients aged 18 years and below.\n\n          -  Patients diagnosed to have keratoconus at presentation and willing for follow - up at\n             regular intervals post treatment.\n\n        Exclusion Criteria:\n\n          -  Any disease causing abnormal topography other than keratoconus.\n\n          -  Any ocular condition predisposing towards poor vision (retinal , lens problems)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "3 Years"
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02008175", 
            "org_study_id": "PED_CXL"
        }, 
        "intervention": {
            "arm_group_label": "Conventional CXL", 
            "description": "Crosslinking was done according to the standard protocol using hypo-osmolar riboflavin (<0.1%) to saturate the cornea following epithelial debridement and ultra - violet light of 370nm with energy density of 3 milliwatts/cm2 with riboflavin and distilled water alternated every 2 minutes was used for the procedure..", 
            "intervention_name": "Conventional CXL", 
            "intervention_type": "Radiation", 
            "other_name": "Conventional collagen cross linking, C3R, Dresden protocol."
        }, 
        "is_fda_regulated": "No", 
        "keyword": "paediatric, keratoconus, collagen cross linking", 
        "lastchanged_date": "December 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chennai", 
                    "country": "India", 
                    "state": "Tamil Nadu", 
                    "zip": "600015"
                }, 
                "name": "Vasan Eye Care Hospital"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of Conventional Collagen Crosslinking in Young Keratoconus.", 
        "overall_official": {
            "affiliation": "Vasan Eye Care Hospital", 
            "last_name": "Dr.Anand Parthasarathy", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The keratometric readings in the steepest and flattest meridians, along with the average K readings were compared pre and post treatment using conventional collagen cross linking technique at 1 month post cross linking.", 
            "measure": "Change in Keratometric indices", 
            "safety_issue": "No", 
            "time_frame": "1 months"
        }, 
        "reference": [
            {
                "PMID": "22633357", 
                "citation": "Vinciguerra P, Alb\u00e9 E, Frueh BE, Trazza S, Epstein D. Two-year corneal cross-linking results in patients younger than 18 years with documented progressive keratoconus. Am J Ophthalmol. 2012 Sep;154(3):520-6. doi: 10.1016/j.ajo.2012.03.020. Epub 2012 May 24."
            }, 
            {
                "PMID": "23347367", 
                "citation": "Chatzis N, Hafezi F. Progression of keratoconus and efficacy of pediatric [corrected] corneal collagen cross-linking in children and adolescents. J Refract Surg. 2012 Nov;28(11):753-8. doi: 10.3928/1081597X-20121011-01. Erratum in: J Refract Surg. 2013 Jan;29(1):72."
            }, 
            {
                "PMID": "22420024", 
                "citation": "Caporossi A, Mazzotta C, Baiocchi S, Caporossi T, Denaro R, Balestrazzi A. Riboflavin-UVA-induced corneal collagen cross-linking in pediatric patients. Cornea. 2012 Mar;31(3):227-31."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02008175"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Vasan Eye Care Hospital", 
            "investigator_full_name": "Dr.ANAND PARTHASARATHY, Dr. Ramesh Hariharan", 
            "investigator_title": "Dr. Anand Parthasarathy", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Comparison of visual rehabilitation was done as improvements noted in Snellen line numbers and best corrected visual acuity (B.C.V.A) converted to decimals, pre and post treatment at 1,3,6,12 months post treatment.", 
            "measure": "Improvement in vision", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "Vasan Eye Care Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vasan Eye Care Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}